Jacqueline Garcia, Md
Clinical trials sponsored by Jacqueline Garcia, Md, explained in plain language.
-
Could a targeted drug boost transplant success in tough blood cancers?
Disease control OngoingThis early-phase study tests whether adding the drug venetoclax to standard transplant preparation and post-transplant maintenance can safely help prevent cancer return in people with high-risk acute myeloid leukemia, myelodysplastic syndromes, or related blood cancers. About 102…
Phase: PHASE1 • Sponsor: Jacqueline Garcia, MD • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
New Three-Drug cocktail targets tough blood cancers
Disease control OngoingThis early-phase study tests the safety of combining three drugs—navitoclax, venetoclax, and decitabine—for people with advanced myeloid blood cancers like acute myeloid leukemia and myelofibrosis. The goal is to find the safest effective dose and see how well the combination wor…
Phase: PHASE1 • Sponsor: Jacqueline Garcia, MD • Aim: Disease control
Last updated May 11, 2026 20:50 UTC